SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
daaqiu
Lv2
150 积分
2023-03-15 加入
最近求助
最近应助
互助留言
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers
16小时前
已完结
Insulin‐like Growth Factor 2‐Tagged Aptamer Chimeras (ITACs) Modular Assembly for Targeted and Efficient Degradation of Two Membrane Proteins
3天前
已完结
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
14天前
已完结
Aptamer functionalized cell membrane for brain and nerve cell sensing with high sensitivity and stability
15天前
已完结
Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice
17天前
已完结
Predicting Therapeutic Antibody Delivery into Human Head and Neck Cancers
27天前
已完结
KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cells
30天前
已完结
Nanoformulation of BRD4-Degrading PROTAC: Improving Druggability To Target the ‘Undruggable’ MYC in Pancreatic Cancer
2个月前
已关闭
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy
2个月前
已完结
Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody-drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: First-in-human dose-escalation study
2个月前
已完结
没有进行任何应助
不需要这篇文献了【积分已退回】
2个月前
文章内容缺失
2个月前
等待时间过长【积分已退回】
2个月前
重新发布【积分已退回】
8个月前
重新发布【积分已退回】
8个月前
感谢,点赞,速度真快,帮大忙了
11个月前
感谢,点赞,速度真快,帮大忙了
11个月前
感谢,点赞,速度真快
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论